Australian battery manufacturer Magnis Energy Technologies Ltd (ASX:MNS) has kicked off commercial production at a new factory in New York state, where it seeks to produce 1 GWh of lithium-ion batteries annually by end-2023.
The Imperium3 New York (iM3NY) plant, covering an area of 22,000 sq m, is located in Endicott and is jointly owned by the Sydney-based firm and its technology partner Charge CCCV LLC (C4V), the Aussie firm said in a bourse filing.
The facility will manufacture cells featuring C4V’s patented Charge CCCV technology, which relies on a bio-mineralised lithium manganese phosphate (BMLMP) cathode. No cobalt and nickel will be applied. In the first few weeks, it will produce several thousand cells that will be tested for quality assurance and first revenues are expected to be brought in late September.
The production process will be powered by electricity from hydropower plants.
Once the 1 GWh goal is reached, the partners intend to boost the factory’s annual manufacturing capacity up to 1.8 GWh, equal to around 15,000 battery cells per day. Their future plans envisage a massive scale-up to 38 GWh of battery cell capacity by the end of 2030.
“Despite a challenging global environment and supply chain issues, we have successfully started production close to schedule which is a major achievement,” said Chaitanya Sharma, CEO of iM3NY, the US arm of Magnis.
Choose your newsletter by Renewables Now. Join for free!